威高血净 (603014)
Shandong Weigao Blood Purification Products Co., Ltd.
K-Line Chart
No K-line data available
Company NameShandong Weigao Blood Purification Products Co., Ltd.
Listing Date2025-05-19
Issue Price26.5RMB
Registered Capital41775.406610k RMB
Legal RepresentativeSong Xiushan
Registered AddressNo. 7 Weigao West Road, Weihai Torch High-tech Industrial Development Zone, Shandong Province
IndustryMedical Devices
Main BusinessFocuses on the research and development, production, and sales of medical blood purification products.
Company ProfileShandong Weigao Blood Purification Products Co., Ltd. was established in 2004. Since its inception, the company has consistently focused on the research and development, production, and sales of medical blood purification products. Its main products include hemodialyzers, hemodialysis tubing, hemodialysis machines, and peritoneal dialysis solutions, covering the fields of hemodialysis and peritoneal dialysis, supplemented by the sales of dialysis-related products. It is one of the domestic manufacturers with the most comprehensive product lines in medical blood purification products.
The company holds 11 Class III medical device product registration certificates. Its products are sold across 31 provinces, municipalities, and autonomous regions in China, ultimately reaching over 6,000 medical institutions such as hospitals and dialysis centers, including more than 1,000 tertiary hospitals. From first- and second-tier cities to third- and fourth-tier cities, extending deep into county towns and townships, and from large tertiary hospitals to primary and secondary hospitals, and further to community and township health centers, the company consistently adheres to and strives to meet the extensive needs of numerous dialysis patients in China, actively fulfilling its corporate mission of 'Extending Life, Delivering Care'.
Stock Details
1. Key Indicators
- Total Shares(W): 41775.41
- Circulating A-Shares(W): 3811.26
- Earnings Per Share(RMB): 0.8500
- Net Assets Per Share(RMB): 16.7133
- Operating Revenue(W RMB): 273605.27
- Total Profit(W RMB): 40640.54
- **Net Profit Attributable to Parent(W RMB) **: 34077.81
- Net Profit Growth Rate(%): 7.92
- Weighted Return on Equity(%): 5.4400
- Operating Cash Flow Per Share(RMB): 1.1620
- Undistributed Profit Per Share(RMB): 3.8322
- Capital Reserve Per Share(RMB): 11.4021
2. Main Business
The main business covers:
- Research, development, production, and sales of medical blood purification products
3. Company Basic Information
- Company Name: Shandong Weigao Blood Purification Products Co., Ltd.
- Listing Date: 2025-05-19
- Industry: Special Purpose Equipment Manufacturing
- Address: No. 7 Weigao West Road, Weihai Torch Hi-tech Industrial Development Zone, Shandong Province
- Website: https://www.wego-healthcare.com/
- Company Profile: The company was established in 2020 through the overall transformation of Weihai Weigao Blood Purification Products Co., Ltd., focusing on the research, development, production, and sales of medical blood purification products.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Maanshan Xinzhong Investment Co., Ltd. | Corporate Entity | 36.86 | 0.97 |
| 2 | MORGAN STANLEY & CO. INTERNATIONAL PLC. | QFII | 18.73 | 0.49 |
| 3 | Founder Fubon CSI Insurance Theme Index Securities Investment Fund (LOF) Class A | Fund | 0.02 | 0.00 |
| 4 | Fullgoal CSI Dividend Low Volatility Exchange Traded Open-End Index Securities Investment Fund | Fund | 0.02 | 0.00 |
| 5 | ICBC Credit Suisse SSE STAR Market Composite Price ETF | Fund | 0.02 | 0.00 |
| 6 | GF SSE STAR Market 50 Constituent ETF Feeder Fund Class A | Fund | 0.02 | 0.00 |
| 7 | Guotai FTSE China State-Owned Enterprise Open Win-Win ETF | Fund | 0.02 | 0.00 |
| 8 | Guotai SSE State-Owned Enterprise Dividend ETF | Fund | 0.02 | 0.00 |
| 9 | Guotai SSE STAR Market 100 ETF | Fund | 0.02 | 0.00 |
| 10 | Huatai-Pinebridge SSE STAR Market Composite ETF | Fund | 0.02 | 0.00 |
5. Concept Sectors
- Recent IPO Stocks
- Margin Trading & Securities Lending
- Approaching Lock-up Expiry
- Restructuring Plan
Remarks
- Data update date: 2025-11-04
- Data source: Public Market Information